383 References 421. Peraita-Adrados R, Romero-Martinez J, Guzman-De Villoria JA, Lillo-Triguero L, Martinez-Gines ML. Comorbidity of narcolepsy with cataplexy and transverse myelitis: a common autoimmune background? A case report. Sleep Med. 2017;33:167-70. 422. Viste R, Soosai J, Vikin T, Thorsby PM, Nilsen KB, Knudsen S. Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy. Neurol Neuroimmunol Neuroinflamm. 2017;4(5):e389. 423. Chen W, Black J, Call P, Mignot E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann Neurol. 2005;58(3):489-90. 424. Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol. 2008;255(12):1900-3. 425. Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004;56(6):905-8. 426. Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology. 2009;73(16):1333-4. 427. Fronczek R, Verschuuren J, Lammers GJ. Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol. 2007;254(11):16078. 428. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993;9(4):138-41. 429. Dash S, Kinney NA, Varghese RT, Garner HR, Feng WC, Anandakrishnan R. Differentiating between cancer and normal tissue samples using multi-hit combinations of genetic mutations. Sci Rep. 2019;9(1):1005. 430. Roya Y, Farzaneh B, Mostafa AD, Mahsa S, Babak Z. Narcolepsy following COVID-19: A case report and review of potential mechanisms. Clin Case Rep. 2023;11(6):e7370. 431. Rodrigues Aguilar AC, Frange C, Huebra L, Dias Gomes AC, Tufik S, Santos Coelho FM. The effects of the COVID-19 pandemic on patients with narcolepsy. J Clin Sleep Med. 2021;17(4):621-7. 432. Nigam M, Hippolyte A, Dodet P, Gales A, Maranci JB, Al-Youssef S, et al. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia. J Clin Sleep Med. 2022;18(1):255-63. 433. Mignot E, Black S. Narcolepsy risk and COVID-19. J Clin Sleep Med. 2020;16(10):18313. 434. Fernandez FX, Flygare J, Grandner MA. Narcolepsy and COVID-19: sleeping on an opportunity? J Clin Sleep Med. 2020;16(8):1415. 435. Mahamid A, Bornstein RJ, Amir H. Pfizer/BioNTech SARS-CoV-2 vaccine as a potential trigger for the development of narcolepsy: a case report. J Clin Sleep Med. 2022;18(10):2503-6. 436. Zhang Z, Gool JK, Sirotkin P, Dauvilliers Y, Barateau L. 2010 and 2013 incidence peaks in narcolepsy and idiopathic hypersomnia linked to type A H1N1 and type B Victoria influenza strains. MedRxiv. 2024. 437. Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol. 2003;184(2):1010-6. 12
RkJQdWJsaXNoZXIy MjY0ODMw